ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

75.76

-2.49 (-3.18%)

At close: Aug 10, 2026, 4:00 PM EDT

76.76

+1.00 (1.32%)

After-hours: Aug 10, 2026, 7:46 PM EDT

ANI Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,623	1,775	1,167	1,129	704	776
Market Cap Growth	-8.18%	52.16%	3.40%	60.35%	-9.25%	116.16%
Enterprise Value	1,873	2,098	1,665	1,218	966.94	987.41
Last Close Price	75.76	78.94	55.28	55.14	40.23	46.08

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.69	23.78	-	64.87	-	-
Forward PE	7.99	10.03	10.72	14.04	14.79	12.86
PEG Ratio	-	0.40	0.40	0.40	1.11	1.02
PS Ratio	1.66	2.01	1.90	2.32	2.22	3.59
PB Ratio	2.72	3.28	2.89	2.61	2.24	2.32
P/TBV Ratio	19.04	-	-	5.13	19.33	48.60
P/FCF Ratio	9.38	-	24.42	10.25	-	1013.74
P/OCF Ratio	8.57	-	18.23	9.49	-	233.45

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.91	2.37	2.71	2.50	3.06	4.57
EV/EBITDA Ratio	12.45	18.88	24.37	11.41	39.68	132.38
EV/EBIT Ratio	12.45	18.88	2850.40	25.93	-	-
EV/FCF Ratio	10.82	-	34.84	11.06	-	1290.74

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.02	1.14	1.46	0.62	0.85	0.80
Debt / EBITDA Ratio	4.06	5.55	9.14	2.68	11.76	38.52
Debt / FCF Ratio	-	-	13.06	2.60	-	375.62
Net Debt / Equity Ratio	0.39	0.60	1.17	0.15	0.76	0.56
Net Debt / EBITDA Ratio	1.56	2.90	6.92	0.61	9.78	25.08
Net Debt / FCF Ratio	-	-	9.90	0.59	-5.95	244.51
Asset Turnover	0.67	0.65	0.56	0.58	0.41	0.35
Inventory Turnover	2.71	2.44	2.02	1.68	1.48	1.41
Quick Ratio	2.29	2.07	1.93	2.63	2.15	2.61
Current Ratio	2.91	2.71	2.72	3.57	3.46	3.68
Return on Equity (ROE)	19.04%	16.16%	-4.18%	4.72%	-13.74%	-15.37%
Return on Assets (ROA)	7.78%	6.67%	0.04%	5.33%	-3.52%	-4.91%
Return on Invested Capital (ROIC)	13.58%	10.30%	0.07%	8.08%	-4.80%	-6.58%
Return on Capital Employed (ROCE)	12.67%	9.86%	0.06%	6.62%	-5.25%	-7.46%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	6.13%	4.21%	-	1.54%	-	-
FCF Yield	10.66%	0.00%	4.09%	9.76%	-	0.10%
Buyback Yield / Dilution	-12.56%	-9.89%	-6.18%	-11.89%	-29.77%	-4.73%
Total Shareholder Return	-12.56%	-9.89%	-6.18%	-11.89%	-29.77%	-4.73%

SEC Filings: 10-K · 10-Q